Literature DB >> 10458165

Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization.

W Yu1, H Nagaoka, M Jankovic, Z Misulovin, H Suh, A Rolink, F Melchers, E Meffre, M C Nussenzweig.   

Abstract

Models of B-cell development in the immune system suggest that only those immature B cells in the bone marrow that undergo receptor editing express V(D)J-recombination-activating genes (RAGs). Here we investigate the regulation of RAG expression in transgenic mice carrying a bacterial artificial chromosome that encodes a green fluorescent protein reporter instead of RAG2. We find that the reporter is expressed in all immature B cells in the bone marrow and spleen. Endogenous RAG messenger RNA is expressed in immature B cells in bone marrow and spleen and decreases by two orders of magnitude as they acquire higher levels of surface immunoglobulin M (IgM). Once RAG expression is stopped it is not re-induced during immune responses. Our findings may help to reconcile a series of apparently contradictory observations, and suggest a new model for the mechanisms that regulate allelic exclusion, receptor editing and tolerance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458165     DOI: 10.1038/23287

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  146 in total

Review 1.  Review article: role of the surrogate light chain and the pre-B-cell receptor in mouse B-cell development.

Authors:  I L Mårtensson; R Ceredig
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  50 million years of chordate evolution: seeking the origins of adaptive immunity.

Authors:  D J Laird; A W De Tomaso; M D Cooper; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers.

Authors:  M P Armengol; M Juan; A Lucas-Martín; M T Fernández-Figueras; D Jaraquemada; T Gallart; R Pujol-Borrell
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 4.  Studies of the humoral immune response.

Authors:  G Kelsoe
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Transcriptional analysis of the B cell germinal center reaction.

Authors:  Ulf Klein; Yuhai Tu; Gustavo A Stolovitzky; Jeffrey L Keller; Joseph Haddad; Vladan Miljkovic; Giorgio Cattoretti; Andrea Califano; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication.

Authors:  Shiaoching Gong; Xiangdong William Yang; Chenjian Li; Nathaniel Heintz
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

7.  Deletion of immunoglobulin beta in developing B cells leads to cell death.

Authors:  Eric Meffre; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

8.  Recent thymic emigrants are biased against the T-helper type 1 and toward the T-helper type 2 effector lineage.

Authors:  Deborah W Hendricks; Pamela J Fink
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

9.  Timing and duration of MHC I positive selection signals are adjusted in the thymus to prevent lineage errors.

Authors:  Motoko Y Kimura; Julien Thomas; Xuguang Tai; Terry I Guinter; Miho Shinzawa; Ruth Etzensperger; Zhenhu Li; Paul Love; Toshinori Nakayama; Alfred Singer
Journal:  Nat Immunol       Date:  2016-09-26       Impact factor: 25.606

10.  Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Xiaojian Wang; Angela Boston; Grant Kolar; Stephen M Jackson; Yong-Jun Liu; Virginia Pascual; J Donald Capra; Patrick C Wilson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.